Clinical Trials Logo

Clinical Trial Summary

The asses and evaluate whether trans apical access for TAVR is associated with apical dysfunction.


Clinical Trial Description

n/a


Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT02210351
Study type Interventional
Source Sheba Medical Center
Contact Danny Spiegelstein, Dr
Phone 972-35307339
Email Danny.Spiegelstein@sheba.health.gov.il
Status Not yet recruiting
Phase N/A
Start date September 2014

See also
  Status Clinical Trial Phase
Completed NCT02956915 - Evaluation of Length of Stay After TF-TAVI
Recruiting NCT05326126 - Microvascular Function in Patients Undergoing Transcatheter Aortic Valve Implant (TAVI) for Severe Symptomatic Aortic Stenosis: Association With Myocardial Fibrosis N/A
Completed NCT04663334 - Change in Coronary Microcirculation and FFR After TAVI in Patients With Cardiovascular Comorbidities
Withdrawn NCT01742598 - Assessment of St Jude Medical Portico Re-sheathable Transapical Aortic Valve System N/A
Withdrawn NCT01927601 - Assessment of Neurologic Injury Subsequent to Transcatheter Aortic Valve Replacement: A Feasibility Study N/A
Completed NCT01787084 - Alternative Access Approaches for Transcatheter Aortic Valve Replace (TAVR) in Inoperable Patients With Aortic Stenosis N/A